- Home
- NDLS vs GNTA Comparison
NDLS vs GNTA Comparison
Compare NDLS & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.01
HOLD
Current Price
$0.87
Company Overview
Basic Information| Metric | NDLS | GNTA |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.7M | 34.0M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | NDLS | GNTA |
|---|---|---|
| Price | $6.01 | $0.87 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 139.8K | 59.0K |
| Earning Date | 04-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $493,271,000.00 | N/A |
| Revenue This Year | $2.29 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.47 | $0.71 |
| 52 Week High | $7.09 | $10.00 |
Technical Indicators
Market Signals| Indicator | NDLS | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 79.04 | 38.81 |
| Support Level | $0.63 | $0.71 |
| Resistance Level | N/A | $1.70 |
| Average True Range (ATR) | 0.58 | 0.09 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 66.87 | 14.98 |
Price Performance
Historical Comparison NDLS
GNTA
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.